If you are looking at non-dilutive funding sources for your start-up, you might be considering applying for an SBIR or STTR grant. In order to be competitive at the national level, all these grants require a rational, thoughtful and convincing commercialization plan. Furthermore, the same plan may be repurposed for many activities including: informing company employees, underpinning the pitch deck and becoming part of the business plan, requested from any diligence team interested in providing a loan, partnering or acquisition.

Get ready for the NIH and NSF 2020 deadlines and other applications by joining us at this informative workshop presented by expert Dr. Elizabeth Smith, PhD, MBA and Principal at SoMax Consulting, LLC. You will learn what elements are required in the commercialization plan segment of the application.

This is part one of a three part workshop series we are offering on this subject. Mark your calendars for the follow-on events:

January 8, 2020. 9 AM. SBIR Phase 2 Commercialization Plan: market penetration, direct customer & end customer, competitive landscape, business strategy, (how you plan to make money)

January 27, 2020. Noon-1 PM. Topics include: Pro forma and revenue streams, patent term and marketing exclusivities.

February 19, 2020: Open Office Hours 10-1 at GIC to review your application

March 2020: Virtual review of the application. By appointment only for select companies only.

About the Speaker

Dr. Elizabeth Smith, PhD, MBA (Principal at SoMax Consulting, LLC) has been working with pre-clinical biohealth executive teams for 20 years on their corporate business development and strategy. She has provided well-received seminars on both commercialization plan writing and SBIR strategy that have been valuable to life-sciences companies such as ours. She has assisted dozens of Maryland companies in writing commercialization plans and has contributed to achieving over $10.0M in non-dilutive funding for her clients.

Thank you to TEDCO for sponsoring this workshop series.